These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model. Hollender A, Kvaloy S, Nome O, Skovlund E, Lote K, Holte H. Ann Oncol; 2002 Jul; 13(7):1099-107. PubMed ID: 12176790 [Abstract] [Full Text] [Related]
5. Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvement. Sakarou M, Eisele L, Dührsen U, Hüttmann A. Eur J Haematol; 2019 Mar; 102(3):241-250. PubMed ID: 30471148 [Abstract] [Full Text] [Related]
6. High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement. Kasamon YL, Jones RJ, Piantadosi S, Ambinder RF, Abrams RA, Borowitz MJ, Morrison C, Smith BD, Flinn IW. Biol Blood Marrow Transplant; 2005 Feb; 11(2):93-100. PubMed ID: 15682069 [Abstract] [Full Text] [Related]
10. Central nervous system relapse in non-Hodgkin lymphoma. A single-center study of 532 patients. Bollen EL, Brouwer RE, Hamers S, Hermans J, Kluin M, Sankatsing SU, A-Tjak RV, Charvat MV, Kluin-Nelemans JC. Arch Neurol; 1997 Jul; 54(7):854-9. PubMed ID: 9236574 [Abstract] [Full Text] [Related]
12. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology. Márky I, Björk O, Forestier E, Jónsson OG, Perkkiö M, Schmiegelow K, Storm-Mathiesen I, Gustafsson G, Nordic Society of Pediatric Hematology and Oncology. J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981 [Abstract] [Full Text] [Related]
13. Predictive factors for central nervous system involvement in non-Hodgkin's lymphoma: significance of very high serum LDH concentrations. Tomita N, Kodama F, Sakai R, Koharasawa H, Hattori M, Taguchi J, Fujita H, Tanabe J, Fujisawa S, Fukawa H, Harano H, Kanamori H, Miyashita H, Matsuzaki M, Ogawa K, Motomura S, Maruta A, Ishigatsubo Y. Leuk Lymphoma; 2000 Jul; 38(3-4):335-43. PubMed ID: 10830740 [Abstract] [Full Text] [Related]
17. Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma. Chua SL, Seymour JF, Streater J, Wolf MM, Januszewicz EH, Prince HM. Leuk Lymphoma; 2002 Sep; 43(9):1783-8. PubMed ID: 12685832 [Abstract] [Full Text] [Related]
18. Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte. Morel P, Dupriez B, Herbrecht R, Bastion Y, Tilly H, Delannoy A, Haioun C, Nouvel C, Bouabdallah K, Baumelou E. Br J Cancer; 1994 Jul; 70(1):154-9. PubMed ID: 7517172 [Abstract] [Full Text] [Related]